Current controversies in the management of patients with early-stage vulvar cancer

Current Opinion in Oncology

Volumn 22, Issue 5, 2010, Pages 481-486

  Oonk, Maaike H ^a   De Hullu, Joanne A ^b   Van Der Zee, Ate G J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

imaging; micrometastases; radiotherapy; sentinel node procedure; vulvar cancer

Indexed keywords

DYE; TRACER;

ASPIRATION BIOPSY; CANCER CLASSIFICATION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; COMPARATIVE STUDY; CYTOLOGY; DIAGNOSTIC ACCURACY; EXCISION; FEASIBILITY STUDY; HUMAN; IMAGING; INGUINAL REGION; LYMPHADENECTOMY; LYMPHOSCINTIGRAPHY; MELANOMA; METASTASIS; MICROMETASTASIS; MORBIDITY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RADIOLOGIST; RESEARCH; REVIEW; SAFETY; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; SQUAMOUS CELL; ULTRASOUND; VULVA CANCER;

FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; NEOPLASM STAGING; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY; VULVAR NEOPLASMS;

EID: 77955431319     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/CCO.0b013e32833c06da     Document Type: Review

References (45)

1. Vander Zee AG, Oonk MH, de Hullu JA, et al. Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J Clin Oncol 2008; 26:884-889.
2. Levenback CF, van Der Zee AG, Rob L, et al. Sentinel lymph node biopsy in patients with gynecologic cancers: Expert panel statement from the International Sentinel Node Society Meeting, February 21, 2008. Gynecol Oncol 2009; 114:151-156.
3. Radziszewski J, Kowalewska M, Jedrzejczak T, et al. The accuracy of the sentinel lymph node concept in early stage squamous cell vulvar carcinoma. Gynecol Oncol 2010; 116:473-477
4. Report on sentinel node procedure in 56 vulvar cancer patients showing an unexpected high false-negative rate of the sentinel node. Authors declare that the main factor responsible for the high false-negative rate was the surgeons' experience
5. OonkMH,vande Nieuwenhof HP, van Der Zee AG, deHullu JA. Update on the sentinel lymph node procedure in vulvar cancer. Expert Rev Anticancer Ther 2010; 10:61-69.
6. Fotiou S, Zarganis P, Vorgias G, et al. Clinical value of preoperative lymphoscintigraphy in patients with early cervical cancer considered for intraoperative lymphatic mapping. Anticancer Res 2010; 30:183-188.
7. Vieira SC, Sousa RB, Tavares MB, et al. Preoperative pelvic lymphoscintigraphy is of limited usefulness for sentinel lymph node detection in cervical cancer. Eur J Obstet Gynecol Reprod Biol 2009; 145:96-99.
8. Mathew MA, Saha AK, Saleem T, et al. Preoperative lymphoscintigraphy before sentinel lymph node biopsy for breast cancer. Breast 2010; 19:28-32.
9. Chakera AH, Friis E, Hesse U, et al. Factors of importance for scintigraphic nonvisualisation of sentinel nodes in breast cancer. Eur J Nucl Med Mol Imaging 2005; 32:286-293. (Pubitemid 40562119)
10. Sadeghi R, Forghani MN, Memar B, et al. How long the lymphoscintigraphy imaging should be continued for sentinel lymph node mapping? Ann Nucl Med 2009; 23:507-510.
11. Heuts EM, van Der Ent FW, van Der Pol HA, et al. Evaluation of early versus delayed lymphoscintigraphic imaging in detecting internal mammary sentinel lymph nodes in breast cancer: a multicenter study to establish an optimal lymphatic mapping protocol. Nucl Med Commun 2006; 27:677-681.
12. De Hullu JA, Oonk MH, Ansink AC, et al. Pitfalls in the sentinel lymph node procedure in vulvar cancer. Gynecol Oncol 2004; 94:10-15.
13. Land R, Herod J, Moskovic E, et al. Routine computerized tomography scanning, groin ultrasound with or without fine needle aspiration cytology in the surgical management of primary squamous cell carcinoma of the vulva. Int J Gynecol Cancer 2006; 16:312-317.
14. Bipat S, Fransen GA, Spijkerboer AM, et al. Is there a role for magnetic resonance imaging in the evaluation of inguinal lymph node metastases in patients with vulva carcinoma? Gynecol Oncol 2006; 103:1001-1006.
15. Kataoka MY, Sala E, Baldwin P, et al. The accuracy of magnetic resonance imaging in staging of vulvar cancer: a retrospective multicentre study. Gynecol Oncol 2010; 117:82-87.
16. 11C]-tyrosine positron emission tomography. Int J Gynecol Cancer 1999; 9:141-146.
17. Cohn DE, Dehdashti F, Gibb RK, et al. Prospective evaluation of positron emission tomography for the detection of groin node metastases from vulvar cancer. Gynecol Oncol 2002; 85:179-184.
18. Grigsby PW. Role of PET in gynaecologic malignancy. Curr Opin Oncol 2009; 21:420-424.
19. Tantipalakorn C, Robertson G, Marsden DE, et al. Outcome and patterns of recurrence for International Federation of Gynecology and Obstetrics (FIGO) stages Iand II squamous cell vulvar cancer. Obstet Gynecol 2009; 113:895-901.
20. Heaps JM, Fu YS, Montz FJ, et al. Surgical-pathologic variables predictive of local recurrence in squamous cell carcinoma of the vulva. Gynecol Oncol 1990; 38:309-314.
21. De Hullu JA, Hollema H, Lolkema S, et al. Vulvar carcinoma: the price of less radical surgery. Cancer 2002; 95:309-314.
22. Horn LC, Wagner S. Frozen section analysis of vulvectomy specimens: results of a 5-year study period. Int J Gynecol Pathol 2010; 29:165-172.
23. Oonk MH, van Hemel BM, Hollema H, et al. Size of sentinel-node metastasis and chances of non-sentinel-node involvement and survival in early stage vulvar cancer: results from GROINSS-V, a multicentre observational study. Lancet Oncol 2010.
24. Stehman FB, Bundy BN, Thomas G, et al. Groin dissection versus groin radiation in carcinoma of the vulva: a Gynecologic Oncology Group study. Int J Radiat Oncol Biol Phys 1992; 24:389-396.
25. McCall AR, Olson MC, Potkul RK. The variation of inguinal lymph node depth in adult women and its importance in planning elective irradiation for vulvar cancer. Cancer 1995; 75:2286-2288.
26. Katz A, Eifel PJ, Jhingran A, Levenback CF. The role of radiation therapy in preventing regional recurrences of invasive squamous cell carcinoma of the vulva. Int J Radiat Oncol Biol Phys 2003; 57:409-418.
27. Homesley HD, Bundy BN, Sedlis A, AdcockL. Radiation therapy versus pelvic node resection for carcinoma of the vulva with positive groin nodes. Obstet Gynecol 1986; 68:733-740.
28. Kunos C, Simpkins F, Gibbons H, et al. Radiation therapy compared with pelvic node resection for node-positive vulvar cancer: a randomized controlled trial. Obstet Gynecol 2009; 114:537-546.
29. Homesley HD, Bundy BN, Sedlis A, et al. Assessment of current International Federation of Gynecology and Obstetrics staging of vulvar carcinoma relative to prognostic factors for survival (a Gynecologic Oncology Group study). Am J Obstet Gynecol 1991; 164:997-1004.
30. Origoni M, Sideri M, GarsiaS, et al. Prognostic value of pathological patterns of lymph node positivity in squamous cell carcinoma of the vulvar stage III and IVA FIGO. Gynecol Oncol 1992; 45:313-316.
31. Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix and endometrium. Int J Gynaecol Obstet 2009; 105:103-104.
32. Hacker NF. Revised FIGO staging for carcinoma of the vulva. Int J Gynaecol Obstet 2009; 105:105-106.
33. Sobin LH, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumours. 7th ed. 2009.
34. Regauer S. Histopathological work-up and interpretation of sentinel lymph nodes removed for vulvar squamous cell carcinoma. Histopathology 2009; 55:174-181.
35. Cormio G, Loizzi V, Carriero C, et al. Groin recurrence in carcinoma of the vulva: management and outcome. Eur J Cancer Care 2009 [Epub ahead of print].
36. Morton DL, Thompson JF, Cochran AJ, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 2006; 355:1307-1317.
37. Van Akkooi AC, Voit CA, Verhoef C, Eggermont AM. New developments in sentinel node staging in melanoma: controversies and alternatives. Curr Opin Oncol 2010; 22:169-177.
38. Phillips GL, Bundy BN, Okagaki T, et al. Malignant melanoma of the vulva treated by radical hemivulvectomy: a prospective study of the Gynecologic Oncology Group. Cancer 1994; 73:2626-2632.
39. Sladden MJ, Balch C, Barzilai DA, et al. Surgical excision margins for primary cutaneous melanoma. Cochrane Database Syst Rev 2009; 4:CD004835.
40. Balch CM, Morton DL, Gershenwald JE, et al. Sentinel node biopsy and standard of care for melanoma. J Am Acad Dermatol 2009; 60:872-875.
41. Faries MB, Wanek LA, Elashoff D, et al. Predictors of occult nodal metastasis in patients with thin melanoma. Arch Surg 2010; 145:137-142.
42. Perrott RE, Glass LF, Reintgen DS, Fenske NA. Reassessing the role of lymphatic mapping and sentinel lymphadenectomy in the management of cutaneous malignant melanoma. J Am Acad Dermatol 2003; 49:567-588.
43. Trifiro G, Travaini LL, Sanvito F, et al. Sentinel node detection by lymphos-cintigraphy and sentinel node biopsy in vulvar melanoma. Eur J Nucl Med Mol Imaging 2010; 37:736-741.
44. De Hullu JA, Hollema H, Hoekstra HJ, et al. Vulvar melanoma: is there a role for sentinel lymph node biopsy? Cancer 2002; 94:486-491.
45. Wechter ME, Gruber SB, Haefner HK, et al. Vulvar melanoma: a report of 20 cases and review of the literature. J Am Acad Dermatol 2004; 50:554-562